Dexcom CGM Gold Study Summary - AMSL Diabetes

Dexcom CGM Gold Study Summary

In addition to the DIaMonD study, the GOLD study presents convincing evidence of glycaemic improvements in patients on MDI therapy and is the first major study to show improvements in key quality of life measures.

Stay informed with AMSL Diabetes

Now you can get all the latest news and updates of our products, events and resources right into your inbox.

Something went wrong. Please try again later!

Send AMSL Diabetes a message

We are always happy to help, send us a message or enquiry

Back to top